The cold supply chain keeps vaccines fresh during distribution, but the current system is nowhere near large enough to distribute the billions of COVID-19 vaccines that the world needs.
Senate Republicans continue to push for sweeping liability protection for companies from coronavirus-related lawsuits, but research and evidence suggests there’s little real risk.
Reports describe a Hong Kong man who was reinfected with the coronavirus after returning from Europe. Does that mean he wasn’t immune after the first infection?
Once a coronavirus vaccine is approved, billions of doses need to be manufactured. Current vaccine production is nowhere near ready, for a variety of reasons, but planning now could help.
The race is on to develop a vaccine for the COVID-19 coronavirus. Australian researchers are leading several major clinical trials that might help bring an end to the deadly disease.
If you have had COVID-19 already, are you protected from another bout of the illness? And is the presence of antibodies in your blood a guarantee of immunity?
Expanding coronavirus testing is one of the most important tasks public health officials are tackling right now. But questions over accuracy of the two main types of tests have rightly caused concern.
Power is visibly draining away from Tom Thabane. But, even at 80 years old, he remains a wily operator, and seems determined to cause maximum trouble to secure his immunity from prosecution.
After your body fights off an infection, antibodies remain in your blood. Two researchers explain how tests identify these antibodies and what the data can be used for.
Officially, not that many people have recovered from the coronavirus. An epidemiologist explains what has to happen for a COVID-19 survivor to get a clean bill of health.
A test that detects antibodies against the coronavirus behind COVID-19 would reveal those people who have already encountered the virus - and therefore who might be ok to resume normal life.